Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000524

Chief Executive Officer sold 1,130 shares at an average $222.12 ($250,999)

  • Chief Executive Officer acquired 1,130 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kummeth Charles R. · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-23 Exercise or conversion : show line 1 in the form +659 $67.46 $44,456 130,648 D
2019-12-23 Sale : show line 2 in the form −659 $222.08 $146,351 129,989 D
2019-12-24 Exercise or conversion : show line 3 in the form +471 $67.46 $31,774 130,460 D
2019-12-24 Sale : show line 4 in the form −471 $222.18 $104,648 129,989 D
Open-market sales · 1,130 sh · avg $222.12 · $250,999

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-12-23 Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) −659 38,689 D
2019-12-24 Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) −471 38,218 D
Loading xslF345X03/edgar.xml…